Short-term Rosuvastatin Treatment for the Prevention of Contrast-induced Acute Kidney Injury in Patients Receiving Moderate or High Volumes of Contrast Media
Lists
Only you see this
Abstract
Periprocedural short-term rosuvastatin treatment is effective in reducing CIAKI and adverse clinical events for patients with diabetes and CKD after their exposure to a moderate volume of contrast medium.
BibTeX
@inproceedings{zhang2015short,
author = {Jiän Zhang and Yi Li and Guizhou Tao and Yundai Chen and Taohong Hu and Xuebin Cao and Quanmin Jing and Xiaozeng Wang and Yingyan Ma and Geng Wang and Haiwei Liu and Bin Wang and Kai Xu and Jing Li and Jie Deng and Yaling Han},
title = {{Short-term Rosuvastatin Treatment for the Prevention of Contrast-induced Acute Kidney Injury in Patients Receiving Moderate or High Volumes of Contrast Media}},
booktitle = {Chinese},
year = {2015},
doi = {10.4103/0366-6999.152620},
}Loading related content...